Citi upgraded Intuitive Surgical (ISRG) to Buy from Neutral with an unchanged price target of $590. The firm believes fundamentals in the U.S. medical technology sector remain “healthy” despite the recent volatility. Shares of Intuitive have fallen with the market, but the company is well positioned to grow sales at a double-digit pace while leveraging earnings, the analyst tells investors in a research note.
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
